comparemela.com

Latest Breaking News On - Laura kauffman - Page 5 : comparemela.com

Groups Recover Together Teams with Pear Therapeutics to Provide People in Recovery Access to Innovative Treatment

News Category Global Banking & Finance Reviews Groups Recover Together Teams with Pear Therapeutics to Provide People in Recovery Access to Innovative Treatment Groups Recover Together Teams with Pear Therapeutics to Provide People in Recovery Access to Innovative Treatment Opioid use disorder (OUD) is often an isolating experience and with COVID-19-related social distancing, fostering recovery is challenging. Recover Together, Inc. (Groups), a leading outpatient treatment provider serving individuals with OUD across eight states, and Pear Therapeutics, Inc., the leader in prescription digital therapeutics (PDTs), today announced a combined effort to treat OUD patients by providing them with Pears innovative technology as well as Groups innovative approach to treatment.

Indiana
United-states
Keely-boyer
Ba-fulton-velez
Karren-williams
Robert-gerwien
Weijia-wang
Meara-murphy
Yuria-maricich
Charles-ruetsch-kathryn-anastassopoulos
Bruce-imbert
Laura-kauffman

Berks County Calendar

Berks County Calendar
berksmontnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from berksmontnews.com Daily Mail and Mail on Sunday newspapers.

Green-hills
Pennsylvania
United-states
Netherlands
Leesport
Exeter-community-library
Delaware
South-africa
Boyertown
South-african
Dutch
Literatour-berks

Pear Therapeutics Announces Publication of Economic Analysis Assessing the Cost-Effectiveness of reSET-O® in Treating Opioid Use Disorder (OUD) |

Pear Therapeutics Announces Publication of Economic Analysis Assessing the Cost-Effectiveness of reSET-O® in Treating Opioid Use Disorder (OUD) By Staff 4 months ago reSET-O® is the first and only FDA-authorized Prescription Digital Therapeutic (PDT) for patients with opioid use disorder (OUD). New economic analysis showed reSET-O to be cost-effective compared to treatment-as-usual alone over 12 weeks, and to have economic dominance when contingency management (CM) was included as part of treatment as usual. BOSTON & SAN FRANCISCO–(BUSINESS WIRE)–Pear Therapeutics, Inc., today announced publication of a new economic analysis describing the cost-effectiveness of reSET-O®, the first and only FDA-authorized Prescription Digital Therapeutic (PDT) for the treatment of opioid use disorder (OUD). The analysis, “

United-states
Corey-mccann
Keely-boyer
Hilaryf-luderer
Ba-fulton-velez
Stephen-braun
Karren-williams
Robert-gerwien
Sam-colman
Yuria-maricich
Charles-ruetsch-kathryn-anastassopoulos
Bruce-imbert

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.